RESULTS	Among microbiologically evaluable patients , 91.4 % ( 139/152 ) of patients receiving levofloxacin 750 mg achieved clinical success vs 88.6 % ( 132/149 ) of patients receiving levofloxacin 500 mg ( 95 % CI -10.0 , 4.2 ) .\